Showing 81 to 100 of 1,709 approvalsPage 5 of 86

Pomalidomide Zentiva

Authorisation: Jul 24, 2024

Zentiva, k.s.

Ixchiq

Authorisation: Jun 28, 2024

Valneva Austria GmbH

Obgemsa

Authorisation: Jun 27, 2024

PIERRE FABRE MEDICAMENT

Obgemsa

Authorisation: Jun 27, 2024

PIERRE FABRE MEDICAMENT

Eribulin Baxter

Authorisation: Jun 27, 2024

Baxter Holding BV

Wezenla

Authorisation: Jun 20, 2024

Amgen Technology (Ireland) UC

Fruzaqla

Authorisation: Jun 20, 2024

Takeda Pharmaceuticals International AG

Tofidence

Authorisation: Jun 20, 2024

Biogen Netherlands BV

Truqap

Authorisation: Jun 17, 2024

ASTRAZENECA AB

Altuvoct

Authorisation: Jun 17, 2024

Swedish Orphan Biovitrum AB (Publ)

Fluenz

Authorisation: Jun 3, 2024

ASTRAZENECA AB

Fluenz

Authorisation: Jun 3, 2024

ASTRAZENECA AB

Agilus

Authorisation: May 29, 2024

Norgine B.V.

Qalsody

Authorisation: May 29, 2024

Biogen Netherlands BV

Neoatricon

Authorisation: May 27, 2024

BREPCO BIOPHARMA LIMITED

Neoatricon

Authorisation: May 27, 2024

BREPCO BIOPHARMA LIMITED

Lytenava

Authorisation: May 27, 2024

OUTLOOK THERAPEUTICS LIMITED

Wyost

Authorisation: May 17, 2024

Sandoz Gmbh

Fabhalta

Authorisation: May 17, 2024

NOVARTIS EUROPHARM LIMITED

Awiqli

Authorisation: May 17, 2024

Novo Nordisk A/S

• Prev
• 1
• 3
• 4
• 5
• 6
• 7
• 86
• Next